Christopher Prue

Chris joined the management team at Rani Therapeutics as Senior Director, Regulatory Affairs in July 2021 with more than 40 years of experience in the pharmaceutical industry, including 38 years in Regulatory Affairs with diversified therapeutic area expertise. His Regulatory submissions experience includes INDs, NDAs, BLAs, and ANDAs in the US as well as CTAs and MAAs in the EU, Canada, South America, and Asia. Previously, Chris held Regulatory and Pharmacovigilance leadership roles in Biotech and Pharma companies including at BioDelivery Sciences Inc., Purdue Pharma LP, Incara Pharmaceuticals, Glaxo Wellcome Inc., and The Upjohn Company. He received his bachelor’s degree in Pharmacy from Purdue University and his MBA, with a major concentration in marketing, from Western Michigan University.